Ilsung re-strengthening strategic alliance with GSK Korea

Published: 2012-04-09 06:56:00

Updated: 2012-04-09 06:56:00

Ilsung Pharm is actively re-seeking strategic alliances with a Korean unit of GlaxoSmilthKline (GSK) over Augmentin, a penicillin antibiotic for treatment of various injections, using its strong sales and marketing force.

Ilsung and GSK Korea agreed Wednesday to jointly market Augmentin under their renewed license agreement.

Under the deal, Dong-A will be in charge of selling Augmentin i...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.